August 2010

Cancer Drug Regimens Definitions are being updated. Find out more

June 2010

• Pazopanib (Votrient®)
  

• PEME_MAINT/(Lung-NSCLC Advanced)
• PAZOPANIB (Metastatic Renal Cell Cancer)

May 2010

• RITUXIMAB (Hematological - CLL)
  
• PACLI*WK (Ovary-2nd Line)
• BEVA (CNS-Glioma)

April 2010

• (Revised) Management of Chemotherapy-Induced Nausea and Vomiting in Adults 
• (Revised) Emetogenic Potential of Individual Chemotherapeutic Agents

March 2010

• CARBOETOP (Endocrine-Neuroendocrine)
• CISPETOP (Endocrine-Neuroendocrine)
• GEFITNIB*FIRST (Lung -NSCLC – Advanced)
• EVEROLIMUS (Genitourinary – Renal)
  
• FULV*ADJ (Gastrointestinal-Pancreas)
• GEMCIT*ADJ (Gastrointestinal-Pancreas)

• Azacitidine (Vidaza ®)
• Degarelix (Firmagon ®)
• Everolimus (Afinitor ®)
• Lapatinib (Tykerb®)
  
• Lenalidomide (Revlimid®)
• Nilotinib (Tasigna®)
• Panitumumab (Vectibix®)
• Temsirolimus (Torisel®)
• Vorinostat (Zolinza®)

February 2010

• Everolimus (Afinitor®)

• CISPAE*MITOTANE (Endocrine-Adrenal)
  
• CISPFU/CISPCAPE-TRAST (Gastrointestinal-Gastric)
  
• mFolfox6 (Gastrointestinal-Adjuvant Colorectal)
  
• mFolfox6 (Gastrointestinal-Metastatic Colorectal)

January 2010

• IMATINIB*ADJ (Sarcoma - GIST)
  
• DEGARELIX (Genitourinary - Prostate)

• Degarelix (Firmagon®)

December 2009

• Azacitidine (Vidaza®)

• Mitotane*Adj (Endocrine-Adrenal)

October 2009

• IRINO-CETUXIMAB (Colorectal - Advanced)
  
• CARBO (Genitourinary - Testis)
  
• PACLI (Kaposi's Sarcoma)
  
• AC→TAXOL WEEKLY ± TRAST (Breast-Neoadjuvant/Adjuvant)
  

September 2009

• VORINOSTAT (Hematological: Non-Hodgkin Lymphoma, low grade)
• FLUD-CYCLO-RITUXIMAB (Hematological: CLL)
• PACLI (Sarcoma - Soft Tissue)
• TOPOCYCLO (Sarcoma - Ewing's)
  

• Vorinostat (Zolinza(R))